Fig. 3From: A novel NCOR2-NTRK1 fusion detected in a patient of lung adenocarcinoma and response to larotrectinib: a case reportNext-generation sequencing findings for the tumor tissue sample. a A novel intergenic region between NCOR2 and NTRK1 fusion variant was identified, and b next-generation sequencing results showing break point of NCOR2-NTRK1 fusionBack to article page